On November 29, Glonhui reported that Star Lake Bioscience (600866.SH) announced it has received a notice of the results of the shareholdings reduction from Yipin Group and its concerted actor Tie Xiaorong. As of November 28, 2024, the reduction period for this shareholding plan has expired, and Yipin Group and its concerted actor Tie Xiaorong have collectively reduced their holdings of the company's shares by 27,906,730 shares through block trade, accounting for 1.68% of the company's total equity. As of the date of this announcement, Yipin Group and its concerted actor Tie Xiaorong hold a total of 282,914,780 shares in the company, accounting for 17.03% of the total equity. This reduction complies with relevant laws and regulations, and there are no violations in the reduction.